News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Lebwohl David
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/06/2023 |
4
| Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 2,574 shares
@ $37.21, valued at
$95.8k
|
|
| 01/04/2023 |
4
| Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Exercised 3,187 restricted stock units
@ $0 |
|
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/09/2021 |
4
| Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 1,200 shares
@ $131.71, valued at
$158.1k
Sold 452 shares
@ $132.62, valued at
$59.9k
Sold 548 shares
@ $134.07, valued at
$73.5k
Sold 200 shares
@ $135.34, valued at
$27.1k
Exercised 2,400 options to buy
@ $12.62, valued at
$30.3k
|
|
| 10/15/2021 |
4
| Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 551 shares
@ $126.92, valued at
$69.9k
Sold 849 shares
@ $127.81, valued at
$108.5k
Sold 225 shares
@ $129.01, valued at
$29k
Sold 525 shares
@ $129.83, valued at
$68.2k
Sold 250 shares
@ $130.47, valued at
$32.6k
Exercised 2,400 options to buy
@ $12.62, valued at
$30.3k
|
|
| 09/27/2021 |
4
| Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Exercised 7,923 options to buy
@ $12.62, valued at
$100k
|
|
| 09/23/2021 |
4
| Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 2,400 shares
@ $149.81, valued at
$359.5k
Exercised 2,400 options to buy
@ $12.62, valued at
$30.3k
|
|
| 09/01/2021 |
4
| Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 200 shares
@ $155.43, valued at
$31.1k
Sold 700 shares
@ $156.7, valued at
$109.7k
Sold 250 shares
@ $157.6, valued at
$39.4k
Sold 1,100 shares
@ $159.19, valued at
$175.1k
Sold 150 shares
@ $160.1, valued at
$24k
Exercised 2,400 options to buy
@ $12.62, valued at
$30.3k
|
|
| 08/11/2021 |
4
| Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Sold 2,400 shares
@ $164.05, valued at
$393.7k
Exercised 2,400 options to buy
@ $12.62, valued at
$30.3k
|
|
| 03/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2020 |
4
| Lebwohl David (EVP, Chief Medical Officer) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $12.62, valued at
$2.5M
|
|
|
|